Cargando…
Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review
BACKGROUND: The pathogenesis of myasthenia gravis (MG) has strong connection with thymic abnormalities. Thymic hyperplasia or thymoma can be found with most patients. Thymectomy is currently one of the regular treatment in clinic, which is, however, still controversial for non-thymomatous MG. This r...
Autores principales: | Yang, Huili, Liu, Dandan, Hong, Xinxin, Sun, Haonan, Zheng, Yu, Yang, Biying, Wang, Wanshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310738/ https://www.ncbi.nlm.nih.gov/pubmed/32569233 http://dx.doi.org/10.1097/MD.0000000000020832 |
Ejemplares similares
-
Outcomes after Thymectomy in Patients with Thymomatous Myasthenia Gravis
por: Rabiou, Sani, et al.
Publicado: (2022) -
Outcomes after thymectomy in non-thymomatous myasthenia gravis
por: Deboever, Nathaniel, et al.
Publicado: (2023) -
Subxiphoid completion thymectomy for refractory non-thymomatous myasthenia gravis
por: Ambrogi, Vincenzo, et al.
Publicado: (2020) -
Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
por: Barnett, Carolina, et al.
Publicado: (2014) -
Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients
por: Yoshida, Mitsuteru, et al.
Publicado: (2020)